CREXMEDIUM SIGNALFINANCIAL10-K

CREX completed the acquisition of Cineplex Digital Media operations while experiencing meaningful growth in accounts receivable and current liabilities alongside a moderate decline in stockholders' equity.

The CDM acquisition represents a strategic expansion that management acknowledges may not deliver anticipated synergies, introducing execution risk. The company's updated language emphasizing the need for adequate operational funding and potential requirement to raise additional financing suggests ongoing liquidity concerns that investors should monitor closely.

Comparing 2026-04-15 vs 2025-03-14View on EDGAR →
FINANCIAL ANALYSIS

The balance sheet reflects substantial growth in accounts receivable and a notable increase in current liabilities, likely driven by the CDM acquisition and expanded operations. However, stockholders' equity declined moderately while cash position improved modestly, creating a mixed financial picture. The overall trajectory suggests operational expansion funded through increased liabilities rather than equity growth, which may pressure the company's financial flexibility going forward.

FINANCIAL STATEMENT CHANGES
Accounts Receivable
Balance Sheet
+81.2%
$10.6M$19.2M

Receivables surged 81.2% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.

Cash & Equivalents
Balance Sheet
+50.3%
$1.0M$1.6M

Cash position surged 50.3% — strong cash generation or capital raise providing significant financial cushion.

Current Liabilities
Balance Sheet
+50.1%
$26.2M$39.3M

Current liabilities surged 50.1% — significant near-term obligations; verify ability to meet short-term debt.

R&D Expense
P&L
+25.8%
$1.3M$1.6M

R&D investment increased 25.8% — signals commitment to future product development, though near-term margin impact.

Stockholders Equity
Balance Sheet
-15.6%
$25.5M$21.5M

Equity decreased 15.6% — buybacks or losses reducing book value, monitor solvency ratios.

LANGUAGE CHANGES
NEW — 2026-04-15
PRIOR — 2025-03-14
ADDED
false --12-31 FY 2025 true true true false Our full Board of Directors oversees our risk management, including our information technology and cybersecurity policies, procedures, and risk assessments.
As of April 10, 2026, the registrant had 10,567,268 shares of common stock outstanding.
Our success and longevity depend on our ability to generate profits from future operations and obtain sufficient capital through financing transactions to satisfy our debt obligations and meet our other business obligations.
Adequate funds for our operations may not be available, requiring us to raise additional financing or else curtail our activities significantly.
We may not realize the growth opportunities that are anticipated from our acquisition of operations of the Cineplex Digital Media business ( CDM ).
+7 more — sign up free →
REMOVED
As of March 14, 2025, the registrant had 10,446,659 shares of common stock outstanding.
A summary of the principal risk factors that make investing in our securities risky and might cause our actual results to differ is set forth below.
Our success and longevity depend on our ability to generate profits from future operations and obtain sufficient capital through financing transactions to refinance our debt obligations, pay any contingent consideration owed to former Reflect stockholders, and meet our other business obligations.
We operate in an intensely competitive industry, and our competitors are developing products and solutions that incorporate artificial intelligence ( AI ) and machine learning ( ML ).
political environment, including those resulting from the change in Presidential Administration and control of Congress, and to regulatory agencies, may result in significant changes to regulatory framework and enforcements.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →